Gefitinib for Advanced Non-Small-Cell Lung Cancer

  • Chen, Lin-Chi MD, PhD

Dr. Chen is a medical oncologist specializing in lung cancer at the Nevada Cancer Institute.

NEJM Journal Watch :p OH200904280000001, 2009. | DOI: 10.1056/OH200904280000001

Patients with EGFR mutations and poor performance status benefited from first-line therapy.

Copyright © 2009 Massachusetts Medical Society. All rights reserved.
View full text